Advertisement

Neo-adjuvant Therapy

  • B. D. Minsky
  • C.-H. Köhne
  • C. Greco

Abstract

A number of advances have been made in the adjuvant management of resectable rectal cancer. In patients with clinically resectable disease, pelvic radiation therapy decreases local recurrence and, in the preoperative setting, increases the chance of sphincter preservation. The addition of systemic chemotherapy further enhances local control and improves survival. The potential additional benefits of preoperative radiation therapy (with or without chemotherapy) include enhanced sphincter preservation and less toxicity.

Keywords

Rectal Cancer Total Mesorectal Excision Preoperative Radiation Preoperative Therapy Sphincter Preservation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Minsky B.D. Management of locally advanced/unresectable rectal cancer. Radiat Oncol Invest 1995;3:97–107.CrossRefGoogle Scholar
  2. 2.
    Minsky B.D., Cohen A.M., Enker W.E., et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the pre-operative approach. J Clin Oncol 1992;10:1218–24.PubMedGoogle Scholar
  3. 3.
    Maghfoor I, Wilkes J, Kuvshinoff B, et al. Neoadjuvant chemoradiotherapy with sphincter-sparing surgery for low lying rectal cancer [sbstract]. Proc ASCO 1997;16:274.Google Scholar
  4. 4.
    Wagman R, Minsky B.D., Cohen A.M., Guillem J.G., Paty P.B. Sphincter preservation with pre-operative radiation therapy (RT) and colo anal anastomosis: long term follow-up [abstract]. Int J Radiat Oncol Biol Phys 1997;39:167.CrossRefGoogle Scholar
  5. 5.
    Grann A, Minsky B.D., Cohen A.M., et al. Preliminary results of pre-operative 5-fluorouracil (5-FU), low dose leucovorin, and concurrent radiation therapy for resectable T3 rectal cancer. Dis Colon Rectum 1997;40:515–22.PubMedCrossRefGoogle Scholar
  6. 6.
    Rouanet P, Fabre J.M., Dubois J.B., et al. Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results. Ann Surg 1995;221:67–73.PubMedCrossRefGoogle Scholar
  7. 7.
    Hyams D.M., Mamounas E.P., Petrelli N, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. A progress report of the National Surgical Adjuvant Breast and Bowel Project protocol RO-3. Dis Colon Rectum 1997;40:131–39.PubMedCrossRefGoogle Scholar
  8. 8.
    Koehler P.R., Feldberg M.A.M., van Waes P.F.G.M. Preoperative staging of rectal cancer with computerized tomography. Accuracy, efficacy, and effect on patient management. Cancer 1984;54:512–16.PubMedCrossRefGoogle Scholar
  9. 9.
    Hadfield M.B., Nicholson A.A., MacDonald A.W., et al. Preoperative staging of rectal carcinoma by magnetic resonance imaging with a pelvic phased-array coil. Br J Surg 1997;84:529–31.PubMedCrossRefGoogle Scholar
  10. 10.
    de Souza N.M., Hall A.S., Puni R, Gilderdale D.J., Young I.R., Kmiot W.A. High resolution magnetic resonance imaging of the anal sphincter using a dedicated endoanal coil. Comparison of magnetic resonance imaging with surgical findings. Dis Colon Rectum 1996;39:926–34.CrossRefGoogle Scholar
  11. 11.
    Hunerbein M, Schlag P.M. Three-dimensional endosonography for staging of rectal cancer. Ann Surg 1997;25:432–38.CrossRefGoogle Scholar
  12. 12.
    Milsom J.W., Czyrko C, Hull T.L., Strong S.A., Fazio V.W. Preoperative biopsy of pararectal lymph nodes in rectal cancer using endoluminal ultrasonography. Dis Colon Rectum 1994;37:364–68.PubMedCrossRefGoogle Scholar
  13. 13.
    Falk P.M., Gupta N.C., Thorson A.G., et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994;37:153–56.PubMedCrossRefGoogle Scholar
  14. 14.
    Bernini A, Deen K.I., Madoff R.D., Wong W.D. Preoperative adjuvant radiation with chemotherapy for rectal cancer: its impact on stage of disease and the role of endorectal ultrasound. Ann Surg Oncol 1996;3:131–35.PubMedCrossRefGoogle Scholar
  15. 15.
    Willett C.G., Warland G, Co en J., Shellito P.C., Compton C.C. Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation. Int J Radiat Oncol Biol Phys 1995;32:57–61.PubMedCrossRefGoogle Scholar
  16. 16.
    Willett C.G., Warland G, Hagan M.P., et al. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995;13:1417–24.PubMedGoogle Scholar
  17. 17.
    Desai G.R., Meyerson R.J., Higashikubo R, et al. Carcinoma of the rectum: possible cellular predictors of metastatic potential and response to radiation therapy. Dis Colon Rectum 1996;39:1090–96.PubMedCrossRefGoogle Scholar
  18. 18.
    Neoptolemos J.P., Oates G.D., Newbold K.M., Robson A.M., McConkey C., Powell J. Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes’ or Jass’ classifications for colorectal cancer. Br J Surg 1995;82:184–87.PubMedCrossRefGoogle Scholar
  19. 19.
    Rich T.A., Sinicrope F, Stephens C, et al. Downstaging of T3 rectal cancer after preoperative infusional chemoradiation is correlated with spontaneous apoptosis index and BCL-2 staining [abstract]. Int J Radiat Oncol Biol Phys 1996;36:259.CrossRefGoogle Scholar
  20. 20.
    Berger C, de Muret A, Garaud P, et al. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys 1997;37:619–27.PubMedCrossRefGoogle Scholar
  21. 21.
    Zlotecki R.A., Mendenhall W.M., Copeland E.M., et al. Preoperative radiotherapy for resectable rectal cancer: improved local control is prognostic for distant metastasis occurrence and survival [abstract]. Int J Radiat Oncol Biol Phys 1996;36:261.CrossRefGoogle Scholar
  22. 22.
    Myerson R.J., Michalski J.M., King M.L., et al. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome. Int J Radiat Oncol Biol Phys 1995;32:41–50.PubMedCrossRefGoogle Scholar
  23. 23.
    Bannon J.P., Marks G.J., Mohiuddin M, Rakinic J, Nong-Zhou J, Nagle D. Radical and local excisional methods of sphinctersparing surgery after high-dose radiation for cancer of the distal 3 em of the rectum. Ann Surg Oncol 1995;2:221–27.PubMedCrossRefGoogle Scholar
  24. 24.
    Bosset J.F., Pavy J.J., Hamers H.P., et al. Determination of the optimal dose of 5-fluorouracil when combined with low dose d,l-leucovorin and irradiation in rectal cancer: results of three consecutive Phase II studies. Eur J Cancer 1993;29:476–86.CrossRefGoogle Scholar
  25. 25.
    Pahlman L, Glimelius B. Pre-or postoperative radiotherapy in rectal and rectosigmoid carcinoma: report from a randomized multicenter trial. Ann Surg 1990;211:187–95.PubMedCrossRefGoogle Scholar
  26. 26.
    Frykholm G.J., Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564–72.PubMedCrossRefGoogle Scholar
  27. 27.
    Boulis-Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Cancer 1984;53:1811–18.PubMedCrossRefGoogle Scholar
  28. 28.
    Minsky B.D. Multidisciplinary management of resectable rectal cancer. Oncology 1996;10:1701–14.PubMedGoogle Scholar
  29. 29.
    Chari R.S., Tyler D.S., Anscher M.S., et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:778–87.PubMedCrossRefGoogle Scholar
  30. 30.
    Stryker S.J., Kiel K.D., Rademaker A, Shaw J.M., Ujiki G.T., Poticha S.M. Preoperative “chemoradiation” for Stages II and II rectal carcinoma. Arch Surg 1996;131:514–19.PubMedCrossRefGoogle Scholar
  31. 31.
    Rich T.A., Skibber J.M., Ajani J.A., et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025–29.PubMedCrossRefGoogle Scholar
  32. 32.
    Rich T.A. Infusional chemoradiation for operable rectal cancer: post-, pre-, or nonoperative management? Oncology 1997;11:295–315.PubMedGoogle Scholar
  33. 33.
    Gerard A, Buyse M, Nordlinger B, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Ann Surg 1988;208:606–16.PubMedCrossRefGoogle Scholar
  34. 34.
    Cedermark B, Johansson H, Rutqvist L.E., Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. Cancer 1995;75:2269–75.PubMedCrossRefGoogle Scholar
  35. 35.
    Higgins G.A., Humphrey E.W., Dwight R.W., Roswit B., Lu L.E. Jr, Keehn R.J. Preoperative radiation and surgery for cancer of the rectum: Veterans Administration Surgical Oncology Group trial II. Cancer 1986;58:352–59.PubMedCrossRefGoogle Scholar
  36. 36.
    Rider W.D., Palmer J.A., Mahoney L.J., Robertson C.T. Preoperative irradiation in operable cancer of the rectum: report of the Toronto Trial. Can J Surg 1977;20:335–38.PubMedGoogle Scholar
  37. 37.
    Roswit B, Higgins G.A. Jr, Keehn R. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: report of a national Veterans Administration randomized study. Cancer 1975;35:1597–602.PubMedCrossRefGoogle Scholar
  38. 38.
    Duncan W. Adjuvant radiotherapy in rectal cancer: the MRC trials. Br J Surg 1985;72:S59–S62.PubMedCrossRefGoogle Scholar
  39. 39.
    Reis Neto J.A., Quilici F.A., Reis J.A. Jr. A comparison of nonoperative vs preoperative radiotherapy in rectal carcinoma: a 10 year randomized trial. Dis Colon Rectum 1989;32:702–10.PubMedCrossRefGoogle Scholar
  40. 40.
    Cedermark B. The Stockholm II trial on preoperative short term radiotherapy in operable rectal carcinoma: a prospective randomized trial [abstract]. Proc ASCO 1994;13:198.Google Scholar
  41. 41.
    Swedish Rectal Cancer Trial. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal cancer. Br J Surg 1993;80:1333–37.CrossRefGoogle Scholar
  42. 42.
    Swedish Rectal Cancer Trial. Local recurrence rate in a randomized multicentre trial of preoperative radiotherapy compared to surgery alone in resectable rectal cancer. Eur J Surg 1996;162:397–402.Google Scholar
  43. 43.
    Goldberg P.A., Nicholls R.J., Porter N.H., Love S, Grimsey J.E. Long-term results of a randomized trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer 1994;30A: 1602–606.PubMedCrossRefGoogle Scholar
  44. 44.
    Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980–87.CrossRefGoogle Scholar
  45. 45.
    Medical Research Council Rectal Cancer Working Party. Randomized trial of surgery alone versus radiotherapy followed by surgery for potentially operable, locally advanced rectal cancer. Lancet 1996;348:1605–609.CrossRefGoogle Scholar
  46. 46.
    Glimelius B, Isacson U, Jung B, Pahlman L. Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favoring preoperative treatment. Int J Radiat Oncol Biol Phys 1997;37:281–87.PubMedCrossRefGoogle Scholar
  47. 47.
    Holm T, Rutqvist L.E., Johansson H, Cedermark B. Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors. Br J Surg 1996;83:964–68.PubMedCrossRefGoogle Scholar
  48. 48.
    Frykholm G.J., Isacsson U., Nygard K, et al. Preoperative radiotherapy in rectal carcinoma: aspects of acute adverse effects and radiation technique. Int J Radiat Oncol Biol Phys 1996;35:1039–48.PubMedCrossRefGoogle Scholar
  49. 49.
    Holm T, Singnomklao T, Rutqvist L.E., Cedermark B. Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer 1996;78:968–76.PubMedCrossRefGoogle Scholar
  50. 50.
    Graf W., Dahlberg M, Osman M.M., Holmberg L., Pahlman L, Glimelius B. Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients. Radiother Oncol 1997;43:133–37.PubMedCrossRefGoogle Scholar
  51. 51.
    Mohiuddin M, Marks J, Bannon J. High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancer. Int J Radiat Oncol Biol Phys 1994;30:845–49.PubMedCrossRefGoogle Scholar
  52. 52.
    Papilion J, Gerard J.P. Role of radiotherapy in anal preservation for cancers of the lower third of the rectum. Int J Radiat Oncol Biol Phys 1990;19:1219–20.CrossRefGoogle Scholar
  53. 53.
    Minsky B.D., Cohen A.M., Enker W.E., Paty P. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31: 553–59.PubMedCrossRefGoogle Scholar
  54. 54.
    National Institutes of Health Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444–50.CrossRefGoogle Scholar
  55. 55.
    Kollmorgen C.F., Meagher A.P., Pemberton J.H., Martenson J.A., Ilstrup D.M. The long term effect of adjuvant postoperative chemoradiotherapy for rectal cancer on bowel function. Ann Surg 1994;220:676–82.PubMedCrossRefGoogle Scholar
  56. 56.
    Paty P.B., Enker W.E., Cohen A.M., Minsky B.D., FriedlanderKlar H. Long-term functional results of coloanal anastomosis for rectal cancer. Am J Surg 1994;167:90–95.PubMedCrossRefGoogle Scholar
  57. 57.
    Birnbaum E.H., Dreznik Z, Myerson R.J., et al. Early effect of external beam radiation on anal sphincter; a study using anal manometry and transrectal ultrasound. Dis Colon Rectum 1992;35:757–61.PubMedCrossRefGoogle Scholar
  58. 58.
    Birnbaum E.H., Meyerson R.J., Fry R.D., Kodner I.J., Fleshman J.W. Chronic effects of pelvic radiation therapy on anorectal function. Dis Colon Rectum 1994;37:909–15.PubMedCrossRefGoogle Scholar
  59. 59.
    Minsky B.D. Adjuvant therapy for rectal cancer: results and controversies. Oncology 1998;12:1129–39.PubMedGoogle Scholar
  60. 60.
    MacFarlane J.K., Ryall R.D., Heald R.J. Mesorectal excision for rectal cancer. Lancet 1993;341:457–60.PubMedCrossRefGoogle Scholar
  61. 61.
    Enker W.E., Thaler H.T., Cranor M.L., Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coli Surg 1995;181:335–45.Google Scholar
  62. 62.
    Haas-Kock D.F.M., Baeten C.G.M.I., Jager J.J., et al. Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 1996;83:781–85.PubMedCrossRefGoogle Scholar
  63. 63.
    Karanjia N.D., Corder A.P., Bearn P, Heald R.J. Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg 1995;81:1224–26.CrossRefGoogle Scholar
  64. 64.
    Aitken R.J. Mesorectal excision for rectal cancer. Br J Surg 1996;83:214–16.PubMedCrossRefGoogle Scholar
  65. 65.
    Withers H.R. Biological basis for altered fractionation schemes. Cancer 1985;55:2086–95.PubMedCrossRefGoogle Scholar
  66. 66.
    Coucke P.A., Cuttat J.F., Mirimanoff R.O. Adjuvant postoperative accelerated hyperfractionated radiotherapy in rectal cancer: a feasibility study. Int J Radiat Oncol BioL Phys 1993;27:885–89.PubMedCrossRefGoogle Scholar
  67. 67.
    Coucke P.A., Sartorelli B., Cuttat J.F., Jeanneret W., Gillet M., Mirimanoff R.O. The rationale to switch from postoperative hyperfractionated accelerated radiotherapy to preoperative hyperfractionated accelerated radiotherapy in rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:181–88.PubMedCrossRefGoogle Scholar
  68. 68.
    Tait D.M., Nahum A.E., Meyer L.C., et al. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother Oncol 1997;42:121–36.PubMedCrossRefGoogle Scholar
  69. 69.
    Duncan W., Arnott S.J., Jack W.J.L., Orr J.A., Kerr G.R., Williams J.R. Results of two randomized trials of neutron therapy in rectal adenocarcinoma. Radiother Oncol 1987;8: 191–98.PubMedCrossRefGoogle Scholar
  70. 70.
    Ichikawa D, Yamaguchi T, Yoshioka Y, Sawai K, Takahashi T. Prognostic evaluation of preoperative combined treatment for advanced cancer in the lower rectum with radiation, intraluminal hyperthermia, and 5-fluorouracil suppository. Am J Surg 1996;171:346–50.PubMedCrossRefGoogle Scholar
  71. 71.
    Ohno S., Tomoda M., Tomisaki S, et al. Improved surgical results after combining preoperative hyperthermia with chemotherapy and radiotherapy for patients with carcinoma of the rectum. Dis Colon Rectum 1997;40:401–406.PubMedCrossRefGoogle Scholar
  72. 72.
    Liu T., Liu Y., He S., Zhang Z., Kligerman M.M. Use of radiation with or without WR-2721 in advanced rectal cancer. Cancer 1992;69:2820–25.PubMedCrossRefGoogle Scholar
  73. 73.
    Stelzer K.J., Koh W.J., Kurtz H, Greer B.E., Griffin T.W. Caffeine consumption is associated with decreased severe late toxicity after radiation to the pelvis. Int J Radiat Oncol Biol Phys 1994;30:411–17.PubMedCrossRefGoogle Scholar
  74. 74.
    Rhomberg W, Eiter H, Hergan K, Schneider B. Inoperable recurrent rectal cancer: results of a prospective trial with radiation therapy and razoxane. Int J Radiat Oncol Biol Phys 1994;30:419–25.PubMedCrossRefGoogle Scholar
  75. 75.
    Tatsuzaki H, Urie M.M., Willett C.G. 3-D comparative study of proton vs X-ray radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 1991;22:369–74.CrossRefGoogle Scholar
  76. 76.
    Isacsson U, Montelius A, Jung B, Glimelius B. Comparative treatment planning between proton and X-ray therapy in locally advanced rectal cancer. Radiother Oncol 1997;41:263–72.CrossRefGoogle Scholar
  77. 77.
    Pitot H.C., Wender D.B., O’Connell M.J., et al. Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. J Clin Oncol 1997;15:2910–19.PubMedGoogle Scholar
  78. 78.
    Cunningham D, Zalcberg J.R., Rath U, et al. Final results of a randomised trial comparing “Tomudex” (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Ann Oncol 1996;961:961–65.CrossRefGoogle Scholar
  79. 79.
    Saltz L.B., Leichman C.G., Young C.W., et al. A fixed-ratio combination of uracil and ftorafur (UFT) with low dose leucovorin. Cancer 1995;75:782–85.PubMedCrossRefGoogle Scholar
  80. 80.
    Gorlick R, Metzger R, Danenberg K, et al. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J Clin Oncol 1998;16:1465–69.PubMedGoogle Scholar
  81. 81.
    Botwood N, James R, Vernon C, Price P. A Phase I study of “Tomudex” (raltitrexed) with radiotherapy (RT) as adjuvant treatment in patients (pt) with operable rectal cancer [abstract]. Proc ASCO 1998;17:277.Google Scholar
  82. 82.
    Rich T.A., Kirichenko A.V. Camptothecin radiation sensitization: mechanisms, schedules, and timing. Oncology 1998;12:114–19.PubMedGoogle Scholar
  83. 83.
    Marsh R.W., Chu N.M., Vauthey I.N., et al. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer 1996;78:217–25.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2001

Authors and Affiliations

  • B. D. Minsky
  • C.-H. Köhne
  • C. Greco

There are no affiliations available

Personalised recommendations